Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single‐institution experienceEvan C. Chen, Aric Parnes, Nathan T. Connell et al.|Haemophilia|2022Cited by 14
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohortJacqueline N. Poston, Rebecca Kruse‐Jarres, Cassandra Bryan et al.|Blood Advances|2024Cited by 10
Treatment of Acquired Hemophilia a with Rituximab and EmicizumabEvan C. Chen, Aric Parnes, William J. Gibson et al.|Blood|2020Cited by 3